Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity
The aim of this study was to identify prognostic markers of complications in patients with severe COVID-19, focusing on comorbidities such as hypertension, coronary artery disease, and diabetes. The study was conducted on 189 patients in tertiary hospitals and divided patients into four groups based...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2025-01-01
|
Series: | BIO Web of Conferences |
Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2025/02/bioconf_mblc2024_04032.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832098672499752960 |
---|---|
author | Khidoyatova Mukhlisa Nabieva Dildora Muxammadieva Sevara Yakupova Svetlana |
author_facet | Khidoyatova Mukhlisa Nabieva Dildora Muxammadieva Sevara Yakupova Svetlana |
author_sort | Khidoyatova Mukhlisa |
collection | DOAJ |
description | The aim of this study was to identify prognostic markers of complications in patients with severe COVID-19, focusing on comorbidities such as hypertension, coronary artery disease, and diabetes. The study was conducted on 189 patients in tertiary hospitals and divided patients into four groups based on the presence of comorbidities. The major complications identified included acute respiratory distress syndrome (ARDS), pulmonary embolism, and atrial fibrillation, which were more common in patients with two or more comorbidities. The study found that comorbidities significantly impacted mortality, with ARDS affecting 29.7% of patients. The results suggest the need for targeted interventions for high-risk patients, especially those with cardiovascular disease and obesity, to improve COVID-19 outcomes. |
format | Article |
id | doaj-art-0fe38e9f43df419781306bff09b77ac9 |
institution | Kabale University |
issn | 2117-4458 |
language | English |
publishDate | 2025-01-01 |
publisher | EDP Sciences |
record_format | Article |
series | BIO Web of Conferences |
spelling | doaj-art-0fe38e9f43df419781306bff09b77ac92025-02-05T10:42:42ZengEDP SciencesBIO Web of Conferences2117-44582025-01-011510403210.1051/bioconf/202515104032bioconf_mblc2024_04032Complications and Adverse Covid-19 Outcomes on Patients with ComorbidityKhidoyatova Mukhlisa0Nabieva Dildora1Muxammadieva Sevara2Yakupova Svetlana3Tashkent Medical AcademyTashkent Medical AcademyTashkent Medical AcademyKazan State University of the Ministry of Health of RussiaThe aim of this study was to identify prognostic markers of complications in patients with severe COVID-19, focusing on comorbidities such as hypertension, coronary artery disease, and diabetes. The study was conducted on 189 patients in tertiary hospitals and divided patients into four groups based on the presence of comorbidities. The major complications identified included acute respiratory distress syndrome (ARDS), pulmonary embolism, and atrial fibrillation, which were more common in patients with two or more comorbidities. The study found that comorbidities significantly impacted mortality, with ARDS affecting 29.7% of patients. The results suggest the need for targeted interventions for high-risk patients, especially those with cardiovascular disease and obesity, to improve COVID-19 outcomes.https://www.bio-conferences.org/articles/bioconf/pdf/2025/02/bioconf_mblc2024_04032.pdf |
spellingShingle | Khidoyatova Mukhlisa Nabieva Dildora Muxammadieva Sevara Yakupova Svetlana Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity BIO Web of Conferences |
title | Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity |
title_full | Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity |
title_fullStr | Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity |
title_full_unstemmed | Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity |
title_short | Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity |
title_sort | complications and adverse covid 19 outcomes on patients with comorbidity |
url | https://www.bio-conferences.org/articles/bioconf/pdf/2025/02/bioconf_mblc2024_04032.pdf |
work_keys_str_mv | AT khidoyatovamukhlisa complicationsandadversecovid19outcomesonpatientswithcomorbidity AT nabievadildora complicationsandadversecovid19outcomesonpatientswithcomorbidity AT muxammadievasevara complicationsandadversecovid19outcomesonpatientswithcomorbidity AT yakupovasvetlana complicationsandadversecovid19outcomesonpatientswithcomorbidity |